Generics substitution, bioequivalence standards, and oversight of international pharmaceutical producers: Complex issues facing the FDA
Year of publication: |
2015
|
---|---|
Authors: | Mathur, Aparna ; Bate, Roger |
Publisher: |
Washington, DC : American Enterprise Institute (AEI) |
Subject: | pharmaceuticals | FDA | drug policy | generic drugs |
Series: | AEI Economics Working Paper ; 2015-05 |
---|---|
Type of publication: | Book / Working Paper |
Type of publication (narrower categories): | Working Paper |
Language: | English |
Other identifiers: | hdl:10419/280525 [Handle] RePEc:aei:rpaper:841152 [RePEc] |
Classification: | A - General Economics and Teaching |
Source: |
-
Mathur, Aparna, (2015)
-
The geographic variation in the cost of the opioid crisis
Brill, Alex, (2018)
-
Evaluation of the Pharmaceutical Industry Investment Program
Commission, Productivity, (2003)
- More ...
-
Does Price Reveal Poor-Quality Drugs? Evidence from 17 Countries
Bate, Roger, (2011)
-
In Whom We Trust: The Role of Certification Agencies in Online Drug Markets
Bate, Roger, (2012)
-
Does price reveal poor-quality drugs? Evidence from 17 countries
Bate, Roger, (2011)
- More ...